|
Market Cap (24-Jun) $14,130,238 (1,586th) |
Close (30-Jun) $0.375 |
Volume (30-Jun) 3,448 |
Shortsold (16-Aug) 1,155 (0.00%) (595th) |
|
52w High $0.79 |
52w Low $0.105 |
P/E - |
EPS -0.08 |
AGN released this announcement to the ASX on 8 September 2022, 8:34. The announcement is not marked as price sensitive, and is 2 page(s) in length and 202.58kb in size.
You can view all announcements from AGN and see how they appear on a price chart on the announcements page.
At the date of this announcement, AGN was 0.000% short sold according to ASIC data. It was ranked the 653rd most shorted stock on the ASX. It is now ranked as the 595th most shorted stock on the ASX with 0.001% of total shares short sold as of the latest reported data (16 August 2024).
| Other Recent Announcements from AGN | |
|---|---|
| ARG-007 Protects Brain Cells in Moderate TBI Model | 22 June 2023, 8:19 |
| Becoming a substantial holder | 20 June 2023, 8:21 |
| Becoming a substantial holder | 13 June 2023, 17:34 |
| Phase 1 Clinical Trial Summary | 8 September 2022, 8:34 |
| Argenica Receives Ethics Approval To Commence Phase 1 Trial | 7 September 2022, 8:11 |
| Appendix 4G & Corporate Governance Statement | 23 August 2022, 18:26 |
| Appendix 4E & Annual Report 30 June 2022 | 23 August 2022, 18:23 |
You must be logged in to post a reply.
